Hutchison China Meditech director tops up stake
Michael Howell, an Independent Non-Executive Director at Hutchison China Meditech, a research and development company majority-owned by Chi-Med, purchased 31,800 shares at 435.00p each on Tuesday. The £138,330 transaction, which takes Howell's interest in the company to 153,600 shares, comes six we
Read more